July 01, 2026 article Taming the “Aggressive Benign” Surgical Oncology Clinics of North America DOI: 10.1016/j.soc.2026.02.003 OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 11 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors 2023 New England Journal of Medicine article Medicine Soft tissue tumor case studies Open access cited by 10 patents 275 citations Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts 2022 Cancer Treatment Reviews article Medicine Musculoskeletal synovial abnormalities and treatments Open access 118 citations Current Management of Desmoid Tumors 2024 JAMA Oncology article Medicine Soft tissue tumor case studies Open access 111 citations Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial 2024 The Lancet article Medicine Musculoskeletal synovial abnormalities and treatments Open access cited by 11 patents 81 citations Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors 2020 Cancer article Medicine Musculoskeletal synovial abnormalities and treatments Open access 72 citations Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours 2022 European Journal of Cancer article Medicine Musculoskeletal synovial abnormalities and treatments Open access 36 citations Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors 2022 Clinical Cancer Research article Medicine Musculoskeletal synovial abnormalities and treatments Open access 35 citations Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study 2025 The Oncologist article Medicine Musculoskeletal synovial abnormalities and treatments Open access 14 citations Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial 2026 The Lancet article Medicine Musculoskeletal synovial abnormalities and treatments Open access 10 citations A phase 2, open-label, adaptive, dose-ranging study with long-term extension to evaluate the safety, tolerability, efficacy, and pharmacokinetics of intra-articular AMB-05X injections in patients with tenosynovial giant cell tumor. 2023 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments Open access 9 citations A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of emactuzumab in patients with tenosynovial giant cell tumor (TANGENT). 2025 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments Open access 4 citations 11 results